June 18, 2015 | Lumenis, the developer of medical software tools in a number of fields, will be acquired by XIO Group for a total of $510 million, at a value of $14 per share. Goldman Sacs advised the deal for the Israeli company and Morgan Stanley for the Chinese investment firm XIO Group. Lumenis is headquartered in Yokneam, Israel and is headed by CEO Tzipi Ozer-Armon.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments